Paradiem LLC cut its stake in shares of Cabot Corporation (NYSE:CBT – Free Report) by 20.3% during the fourth quarter, Holdings Channel reports. The firm owned 118,851 shares of the specialty chemicals company’s stock after selling 30,246 shares during the quarter. Cabot makes up approximately 1.9% of Paradiem LLC’s portfolio, making the stock its 24th largest holding. Paradiem LLC’s holdings in Cabot were worth $7,877,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. CIBC Bancorp USA Inc. acquired a new stake in Cabot during the 3rd quarter worth about $440,000. Danske Bank A S acquired a new stake in shares of Cabot during the third quarter valued at approximately $38,000. Caitong International Asset Management Co. Ltd lifted its position in shares of Cabot by 709.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company’s stock valued at $41,000 after acquiring an additional 468 shares in the last quarter. Advisory Services Network LLC purchased a new position in Cabot during the 3rd quarter worth approximately $57,000. Finally, Morningstar Investment Management LLC acquired a new stake in Cabot during the 3rd quarter valued at $447,000. Institutional investors and hedge funds own 93.18% of the company’s stock.
Cabot Stock Performance
Shares of NYSE CBT opened at $68.75 on Friday. The business’s 50-day simple moving average is $72.98 and its 200-day simple moving average is $70.72. Cabot Corporation has a 52 week low of $58.33 and a 52 week high of $84.54. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.09 and a current ratio of 1.67. The firm has a market cap of $3.59 billion, a price-to-earnings ratio of 12.04, a P/E/G ratio of 8.96 and a beta of 0.86.
Cabot Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Friday, February 27th were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date was Friday, February 27th. Cabot’s dividend payout ratio is 31.52%.
Analysts Set New Price Targets
Several brokerages have recently commented on CBT. Zacks Research raised Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. JPMorgan Chase & Co. lowered their target price on Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research note on Friday, November 28th. Mizuho set a $75.00 target price on Cabot and gave the company a “neutral” rating in a report on Wednesday, February 4th. UBS Group increased their price target on shares of Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Finally, Jefferies Financial Group restated a “buy” rating and set a $85.00 price target on shares of Cabot in a report on Wednesday, February 4th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Cabot presently has an average rating of “Hold” and a consensus target price of $73.75.
Get Our Latest Stock Analysis on CBT
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Further Reading
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
